Best evidence summary for smoking cessation management in patients with coronary heart disease

Article type
Authors
Li Y1, Zhihua L1, Fan W1, Bai Y1
1Xiamen Cardiovascular Hospital Of Xiamen University, Fujian Province, Xiamen City, China
Abstract
"Background:At present, the number of cardiovascular disease patients in China is about 330 million, of which coronary heart disease accounts for 11.39 million, the mortality rate is on the rise. Smoking increases the risk of coronary heart disease and death. Quitting smoking can reduce the risk of cardiovascular events and is also the most cost-effective intervention to save lives. Although high-quality smoking cessation guidelines have been published in various countries, they have not taken into account the demographic characteristics of coronary heart disease patients. Therefore, it is of great significance to form the best evidence for standardized smoking cessation management for coronary heart disease patients.
Objectives:To retrieve, evaluate, and integrate the best evidence of smoking cessation management in patients with coronary heart disease, aiming to provide references for clinical medical and nursing staff to improve smoking cessation intervention measures in patients with coronary heart disease.
Methods:The computer system retrieved Clinical practice guidelines, evidence summary, expert consensus, systematic evaluation, Meta-analysis, randomized controlled trials on smoking cessation management of patients with coronary heart disease in BMJ Best Clinical Practice, UpToDate, National Institute of Health and Clinical Optimization Guide Network (NICE), Scottish Inter-college Guide Network (SIGN), Guide International Network (GIN), Medical Access, Joanna Briggs Institute Evidence-based Health Care Center Library (JBI), Cochrane Library, PubMed, Web of Science,Embase, CINAHL, Wanfang Database, China HowNet, China Biomedical Literature Database, Springer Link, OVID, VIP and Superstar Journal Database. The retrieval time wasfrom the establishment of the database to September 7, 2023. Two researchers independently evaluated the quality of the literature, and extracted relevant evidence from the included literature.
Results: A total of 11 articleswere incorporated, including 3 guidelines, 5 systematic reviews, and 3 expert consensus. Twenty-five pieces of evidence were summarized from 6 aspects, including smoking cessation assessment, general principles, intervention measures (behavioral intervention, smoking cessation drugs, traditional Chinese medicine intervention, perioperative intervention), health education, follow-up and effect evaluation.
Conclusion: This study summarizes the best evidence of smoking cessation management in patients with coronary heart disease, which can provide patients with scientific and effective smoking cessation help, and promote the transformation of evidence-based knowledge into clinical practice."